ロード中...
A New Side Effect of Intravitreal Dexamethasone Implant (Ozurdex®)
Dexamethasone implant, 0,7 mg (Ozurdex, Allergan, Inc., Irvine, CA, USA), is drug mostly used in the treatment of the diabetic macular edema and edema related to retinal vein occlusion. By reporting this case we aimed to report a new side effect of 0.7 mg intravitreal dexamethasone implant that has...
保存先:
| 出版年: | Case Rep Ophthalmol Med |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Hindawi
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5643104/ https://ncbi.nlm.nih.gov/pubmed/29098101 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2017/6369085 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|